Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 7/20 | 0.45 |
| ▸ | CA2 | P00918 | 7/20 | 0.45 |
| ▸ | CA12 | O43570 | 6/20 | 0.45 |
| ▸ | CA7 | P43166 | 6/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.45 |
| ▸ | CA9 | Q16790 | 4/20 | 0.44 |
| ▸ | APOB | P04114 | 5/20 | 0.42 |
| ▸ | MTTP | P55157 | 4/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10405252 | 0.83 | CA1 (0.61) | MAPTNPC1RAB9ACA1CA2 | |
| SCHEMBL5737230 | 0.82 | CA1 (0.42) | MAPTRAB9ACA1CA2CA12 | |
| SCHEMBL3441786 | 0.79 | CA1 (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL2075952 | 0.79 | NPC1 (0.52) | MAPTNPC1RAB9ACA1CA2 | |
| SCHEMBL4607263 | 0.79 | CA1 (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL2283276 | 0.78 | MAPT (0.50) | MAPTNPC1RAB9A | |
| SCHEMBL4124063 | 0.76 | CA1 (0.39) | CA1CA2CA12CA7CA14 | |
| SCHEMBL7690123 | 0.76 | CA1 (0.43) | RAB9ACA1CA2CA12CA7 | |
| SCHEMBL7248144 | 0.76 | CA1 (0.43) | RAB9ACA1CA2CA12CA7 | |
| SCHEMBL4607791 | 0.75 | APOB (0.36) | CA1CA2CA12CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1487781-B1 | PROCESS FOR PREPARING 2-AMINOINDAN DERIVATIVES | NOVARTIS AG (CH) | 2008-07-23 | — | — | EP | claimed |
| CN-1268605-C | Process for preparing 2-aminoindan derivatives | NOVARTIS AG (CH) | 2006-08-09 | — | — | CN | claimed |
| US-6933410-B2 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | NOVARTIS AG (CH) | 2005-08-23 | — | — | US | claimed |
| CN-1639111-A | Process for preparing 2-aminoindan derivatives | NOVARTIS AG (CH) | 2005-07-13 | — | — | CN | claimed |
| US-20030187301-A1 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | NOVARTIS AG (CH) | 2003-10-02 | — | — | US | claimed |
| EP-1487781-B1 | PROCESS FOR PREPARING 2-AMINOINDAN DERIVATIVES | NOVARTIS AG (CH) | 2008-07-23 | — | — | EP | disclosed |
| EP-1487781-B1 | PROCESS FOR PREPARING 2-AMINOINDAN DERIVATIVES | NOVARTIS AG (CH) | 2008-07-23 | — | — | EP | disclosed |
| CN-1268605-C | Process for preparing 2-aminoindan derivatives | NOVARTIS AG (CH) | 2006-08-09 | — | — | CN | disclosed |
| US-6933410-B2 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | NOVARTIS AG (CH) | 2005-08-23 | — | — | US | disclosed |
| CN-1639111-A | Process for preparing 2-aminoindan derivatives | NOVARTIS AG (CH) | 2005-07-13 | — | — | CN | disclosed |
| US-20030187301-A1 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | NOVARTIS AG (CH) | 2003-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187301-A1 | Process for preparing 5,6-diethyl-2,3-dihydro-1H-inden-2-amine | NAT1, AADAC, IDH3A | MAPT 2277/4885NPC1 2911/4885RAB9A 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.